Your browser doesn't support javascript.
loading
A phase 1 study of the pan-bromodomain and extraterminal inhibitor mivebresib (ABBV-075) alone or in combination with venetoclax in patients with relapsed/refractory acute myeloid leukemia.
Borthakur, Gautam; Odenike, Olatoyosi; Aldoss, Ibrahim; Rizzieri, David A; Prebet, Thomas; Chen, Chris; Popovic, Relja; Modi, Dimple A; Joshi, Rujuta H; Wolff, Johannes E; Jonas, Brian A.
Afiliación
  • Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Odenike O; Section of Hematology/Oncology, The University of Chicago Medicine Comprehensive Cancer Center, Chicago, Illinois.
  • Aldoss I; Gehr Family Center for Leukemia Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, California.
  • Rizzieri DA; Division of Hematologic Malignancies and Cellular Therapy, Duke University Medical Center, Durham, North Carolina.
  • Prebet T; Section of Hematology, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut.
  • Chen C; AbbVie Inc, North Chicago, Illinois.
  • Popovic R; AbbVie Inc, North Chicago, Illinois.
  • Modi DA; AbbVie Inc, North Chicago, Illinois.
  • Joshi RH; AbbVie Inc, North Chicago, Illinois.
  • Wolff JE; AbbVie Inc, North Chicago, Illinois.
  • Jonas BA; Division of Hematology and Oncology, Department of Internal Medicine, University of California-Davis School of Medicine, Sacramento, California.
Cancer ; 127(16): 2943-2953, 2021 08 15.
Article en En | MEDLINE | ID: mdl-33934351

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos